Cancer test company says vendor mistakenly sent letters to 400 patients that they may have disease
Grail, Inc. said Friday that it erroneously sent out hundreds of form letters that mistakenly told patients they had cancer when many of them had not yet taken the blood test.
85,000 hedge trimmers recalled over laceration risk
The risk of users getting cut has led to Chevron North America issuing a recall of 85,000 hedge trimmers in the U.S., according to a recall notice Thursday from the CPSC.
Peloton rebrands itself with more app membership tiers, including a free version
Peloton Interactive announced changes on Wednesday that allow everyone to access many of the company's fitness classes and workouts, no matter where they are.
AI is already speeding up drug development and reducing animal testing
AI-driven technology developed by VeriSIM Life accelerates drug development and reduces the need for animal testing by analyzing pharmaceuticals before human trials.
AI and machine learning may speed drug development, manufacturing: FDA
The FDA published two discussion papers this week about areas artificial intelligence and machine learning may improve drug development and manufacturing processes.
Boston hospital to use $100 million gift for immunology, inflammation research
A biotech entrepreneur has gifted $100 million to Boston’s Brigham and Women's Hospital which will use the donation to establish a new institute to study immunology and inflammation.
FDA debates health risks of birth control without prescription
The FDA may approve birth control pills over-the-counter by the summer, but expressed hesitation due to concerns over women misreading labels on the drug's health concerns.
This is the way? 'JEDI Center' uses magic mushrooms for guided 'journeys'
Entrepreneurs in Vancouver are offering psilocybin "journeys" for clients seeking what they describe as "the highest level of self-discovery and personal development."
Jenny Craig to close its doors, lay off employees: Report
Weight loss program Jenny Craig will be closing the doors of its retail centers in the U.S. and Canada, after the company was unable to secure additional funding, according to reports Wednesday.
What Is Ozempic and why is it such a big deal right now?
Demand for medications including Ozempic, for weight loss use, led to shortages that sometimes deprived people with diabetes of their prescription refills.
Narcan maker aims to make overdose reversal drug more affordable, company says
Emergent BioSolutions is aiming to make Narcan more affordable after the Food and Drug Administration approved sales of the live-saving without a prescription.
US spending $5 billion to increase new COVID vaccines' speed of development
The U.S. government is spending more than $5 billion to increase the speed of development of new COVID-19 vaccines and treatments, according to officials.
Washington pot regulators halt operations at several farms over pesticide concerns
Marijuana regulators in Washington state halted operations at several outdoor farms and processors after testing revealed the presence of a dangerous pesticide.
Abortion pill manufacturer Danco Laboratories slams Texas judge's ruling halting FDA approval of mifepristone
Drug manufacturer Danco Laboratories slammed a decision by a Texas judge to halt FDA approval of their abortion pill Mifeprex (mifepristone), vowing to appeal the decision.
Smoked salmon product recalled from Florida Publix supermarkets: FDA
Seven Seas International is recalling some of their Biltmore Smoked Sockeye Salmon products purchased in Publix stores before March 14, according to the Food and Drug Administration.
Novo Nordisk to lower insulin prices by 75%
Novo Nordisk announced plans Tuesday to lower the cost of several of its insulin products by up to 75% for people living with Type 1 and Type 2 diabetes.
CDC investigating after more than 300 sickened aboard Princess Cruises ship
The Ruby Princess, of the Princess Cruises lines, had more than 300 passengers and crew fall ill with symptoms that included vomiting and diarrhea during the Caribbean trip.
FDA to decide on full approval of Alzheimer's treatment Leqembi in early July
The FDA will decide on July 6 whether to grant full approval to the new Alzheimer's treatment Leqembi, Japanese drugmaker Eisai and its U.S. partner Biogen said.
Altria buying vape maker NJOY for $2.75B
Altria will buy vape-maker NJOY and absorb the company’s NJOY ACE production as the only e-vapor product with market authorizations from the U.S. Food and Drug Administration (FDA).
Russell Stover recalls Sugar Free Peanut Butter Cups after learning of potential for undeclared pecans
Russell Stover recalled its Sugar Free Peanut Butter Cups after learning packages might contain Sugar Free Pecan Delights -- a life-threatening error for those with a pecan allergy.